SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-056996
Filing Date
2024-05-09
Accepted
2024-05-09 16:15:29
Documents
44
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mnov-20240331.htm   iXBRL 10-Q 732427
2 EX-31.1 mnov-ex31_1.htm EX-31.1 13563
3 EX-31.2 mnov-ex31_2.htm EX-31.2 13967
4 EX-32.1 mnov-ex32_1.htm EX-32.1 9248
5 EX-32.2 mnov-ex32_2.htm EX-32.2 9589
  Complete submission text file 0000950170-24-056996.txt   3552532

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT mnov-20240331.xsd EX-101.SCH 622828
48 EXTRACTED XBRL INSTANCE DOCUMENT mnov-20240331_htm.xml XML 442134
Mailing Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

IRS No.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33185 | Film No.: 24930861
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)